Effects of Multimodal Pain Therapy in Patients With Mixed Chronic Pain Syndromes (IMPERApain)

This study is currently recruiting participants.
Verified November 2012 by Klinikum St. Georg gGmbH
Sponsor:
Information provided by (Responsible Party):
Armin Sablotzki, MD, Klinikum St. Georg gGmbH
ClinicalTrials.gov Identifier:
NCT01346202
First received: April 27, 2011
Last updated: November 12, 2012
Last verified: November 2012
  Purpose

Complex and chronified pain syndromes requires a specialized therapeutic concept. From patients with chronic low back pain the investigators know, that an interdisciplinary multi-modal approach may improve the therapeutic success. In this observational study the investigators investigated if the multi-modal pain therapy is also effective in patients with mixed chronic pain syndromes.


Condition
Chronic Pain

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Influence of a Multimodal Day-unit Pain Therapy on Pain Experience, Pain-related Disability and Depression in Patients With Chronic Pain Syndromes

Resource links provided by NLM:


Further study details as provided by Klinikum St. Georg gGmbH:

Primary Outcome Measures:
  • intensity of pain [ Time Frame: Change from Baseline in intensity of pain at 1 year ] [ Designated as safety issue: No ]
    pain intensity 1 year after multi-modale therapy compared with pain intensity before treatment


Secondary Outcome Measures:
  • pain disability index [ Time Frame: Change from Baseline in pain disability index at 6 months ] [ Designated as safety issue: No ]
    pain disability index 6 month after multi-modale therapy compared with pain disability index before treatment


Estimated Enrollment: 260
Study Start Date: January 2011
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
chronic pain
260 consecutive patients with verified chronic pain syndromes

Detailed Description:

The multi-modal pain therapy includes:

  • specific drug therapy
  • pain education
  • psychological therapy
  • physical therapy
  • behavioral therapy
  • work hardening
  • bio-feedback
  • ergotherapy
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

260 consecutive patients with chronic pain syndromes

Criteria

Inclusion Criteria:

  • age >= 18 years and <= 65 years
  • verified chronic pain for more than 6 month

Exclusion Criteria:

  • application for a pension
  • non-accordance with multi-modal pain therapy
  • dominant geriatric symptoms
  • dominant psychiatric symptoms
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01346202

Contacts
Contact: Armin R Sablotzki, MD, PhD 0049-341-9092570 armin.sablotzki@sanktgeorg.de
Contact: Carsten Funke, MD 0049-341-9092575 carsten.funke@sanktgeorg.de

Locations
Germany
Klinikum St. Georg, Pain Center Recruiting
Leipzig, Sachsen, Germany, 04129
Contact: Armin R Sablotzki, MD, PhD     0049-341-9091570     armin.sablotzki@sanktgeorg.de    
Sub-Investigator: Annedore Hoera            
Sub-Investigator: Patricia Hungerland            
Sponsors and Collaborators
Klinikum St. Georg gGmbH
Investigators
Principal Investigator: Armin R Sablotzki, MD, PhD Klinikum St. Georg
  More Information

Additional Information:
No publications provided

Responsible Party: Armin Sablotzki, MD, Prof. Dr. med., Klinikum St. Georg gGmbH
ClinicalTrials.gov Identifier: NCT01346202     History of Changes
Other Study ID Numbers: EK-BR-28/10-1
Study First Received: April 27, 2011
Last Updated: November 12, 2012
Health Authority: Germany: Ethics Commission

Keywords provided by Klinikum St. Georg gGmbH:
multi-modal pain therapy, chronic pain

ClinicalTrials.gov processed this record on June 18, 2013